Drug protein binding in chronic renal failure: Evaluation of nine drugs
- 1 May 1988
- journal article
- research article
- Published by Elsevier in Kidney International
- Vol. 33 (5) , 996-1004
- https://doi.org/10.1038/ki.1988.99
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Isolation and chemical identification of inhibitors of plasma ligand bindingKidney International, 1986
- Diazepam and lidocaine plasma protein binding in renal diseaseClinical Pharmacology & Therapeutics, 1982
- Suppression of tubular anion transport by an inhibitor of serum protein binding in uremiaKidney International, 1981
- Isolation of peptides from uremic plasma that inhibit phenytoin binding to normal plasma proteinsClinical Pharmacology & Therapeutics, 1981
- Plasma protein binding in uremia: Extraction and characterization of an inhibitorKidney International, 1980
- Impaired Plasma Phenytoin Binding in UremiaNephron, 1980
- Increased Plasma Protein Binding of Propranolol and Chlorpromazine Mediated by Disease-Induced Elevations of Plasma α1Acid GlycoproteinNew England Journal of Medicine, 1978
- Morphine and phenytoin binding to plasma proteins in renal and hepatic failureClinical Pharmacology & Therapeutics, 1975
- The Alteration of Plasma Proteins in Uremia as Reflected in their Ability to Bind Digitoxin and DiphenylhydantoinPharmacology, 1972
- Protein Binding of Diphenylhydantoin and Desmethylimipramine in Plasma from Patients with Poor Renal FunctionNew England Journal of Medicine, 1971